Leaderboard

En | De
Sie sind hier: Gastroenterologie » Leber » Leberzirrhose 03. Januar 2026
Suchen
medline.ch
Leberzirrhose
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Hepatitis
Leberzirrhose
Neoplasie
Portale Hypertonie
Anderes
Magen-Darm
Oesophagus
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 1885  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 37689  
   
Prurigo Nodularis Increases Risk of Non-alcoholic Fatty Liver Disease and Liver Cirrhosis: A Global-federated Retrospective Cohort Study.
In Vivo
Chang HC, Lin CY, Lu HY, Chiu TM, Lo SW, Wu CL, Liao WC, Fang YJ, Gau SY.
PMID: 41482383 [PubMed - indexed for MEDLINE]


Clinical, pathological characteristics and long-term outcomes of hepatitis B virus related cirrhosis in pediatric observational study.
World J Gastroenterol
Zhao BK, Li Y, Jiang YY, Li ML, Jiang Y, Zhu L, Guo CN, Liu SH, Chen L, Jiang LN, Niu JQ, Zhao JM.
PMID: 41480325 [PubMed - indexed for MEDLINE]


Novel regulators of hepatic macrophages in liver fibrosis.
Front Immunol
Tang X, Bai M, Du X, Wang H, Liu M, Fu X, Zhang H, Liang S, Wang L.
PMID: 41479922 [PubMed - indexed for MEDLINE]


Pancreatic steatosis is not associated with advanced steatohepatitis or fibrosis in metabolic dysfunction-associated steatotic liver disease.
World J Gastroenterol
Heymann G, Rahman S, Kats D, Banini BA, Gaddam S, Aslanian E, Boateng S, Israel G, Muniraj T.
PMID: 41479758 [PubMed - indexed for MEDLINE]


Precision Targeting of Hepatic Stellate Cells: Nanotherapeutic Strategies for Liver Fibrosis Regression.
Wiley Interdiscip Rev Nanomed Nanobiotechnol
Ma X, Chen D, Zhao M, Hu H.
PMID: 41479385 [PubMed - indexed for MEDLINE]


Diagnostic Utility of Apparent Diffusion Coefficient Values of Spleen and Liver in Assessment of Severity of Portal Hypertension and Liver Cirrhosis.
Niger Postgrad Med J
Siddhardha K, Jalaludheen S, Aiyappan SK.
PMID: 41479196 [PubMed - indexed for MEDLINE]


Masson's Trichrome Staining Technique to Evaluate Tissue Fibrosis.
Methods Mol Biol
Islam MA, Kumar S.
PMID: 41478970 [PubMed - indexed for MEDLINE]


Understanding Left Ventricular Dysfunction in Liver Cirrhosis: Key Insights for Primary Care.
Mymensingh Med J
Panda S, Singhai A, Shah B, Atlani M.
PMID: 41474917 [PubMed - indexed for MEDLINE]


Demographic Inequalities in Mortality Due to Hepatocellular Cancer in Male Patients With Alcoholic Cirrhosis in the United States: A CDC WONDER Database Analysis.
Cureus
Khan F, Ahmad A, Ayyazuddin M, Awan AR, Arshad S, Nadeem MA.
PMID: 41473632 [PubMed]


The Effects of Flaxseed Consumption on Frailty and Sarcopenia in Patients With Liver Cirrhosis: An Open-Labeled Randomized Controlled Clinical Trial.
Food Sci Nutr
Pashayee-Khamene F, Hekmatdoost A, Haidari F, Anushiravani A, Hatami B, Sadeghi A, Ahmadi-Engali K, Helli B.
PMID: 41473401 [PubMed]


Interactions Between Sarcopenia, Physical Frailty and Resting Energy Expenditure in Cirrhosis and Portal Hypertension.
Nutrients
Jacob R, Craik J, Pudipeddi A, Park L, Aw G, Ngu NLY, Sundaram P, Vidot H, Valliani T, Gill M, Staudenmann D, Bowen D, Strasser SI, McCaughan GW, Liu K.
PMID: 41470789 [PubMed - indexed for MEDLINE]


Evaluation of Prognosis in Cirrhotic Patients with Esophageal Variceal Bleeding Using Non-Invasive Scores.
Medicina (Kaunas)
K, Sar, , Ölmez .
PMID: 41470196 [PubMed - indexed for MEDLINE]


Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells.
Cell Biosci
Pan X, Gao T, Wang B.
PMID: 41469927 [PubMed - as supplied by publisher]


Diagnostic Performance of PSMA PET/MRI in Characterizing LI-RADS 3 Observations in Patients with Cirrhosis.
J Nucl Med
Catalano OA, Bhan I, Asmundo L, Bradley WR, Fonderico M, Zhang ML, Mojtahed A, Anderson MA, Herold A, Hajati A, Pena-Trujillo V, Caravan PD, Harrington SG, Esfahani SA, Mahmood U, Elias N, Walsh EP, Pratt DS, Scherrer AB, Ellis H, Bethea ED, Sirlin C, Kambadakone AR, Ryan D, Lau-Min K.
PMID: 41469151 [PubMed - as supplied by publisher]


Correlation between serum bile acids with severity of liver cirrhosis: A case-control study.
Bioinformation
Doshi S, Sonawane P, Agrawal U, Munshi AA.
PMID: 41466655 [PubMed]


SGLT2 Inhibitors and Liver Cirrhosis: Hype or Hope?
Life (Basel)
Brusnic O, Onisor DM, Boicean A, Porr C, Sofonea FD, Anderco P, Ichim C.
PMID: 41465728 [PubMed]


Angiotensin-Converting Enzyme Inhibitors to Prevent Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Scientific Speculation or an Opportunity to Improve Real Clinical Practice?
Int J Mol Sci
Seidita A, Buscemi C, Di Liberto D, Pistone M, Maestri S, Cavallo G, Cosenza S, Spagnuolo G, Giuliano A, Carlisi D, Pratelli G, Mandreucci F, Carroccio A.
PMID: 41465213 [PubMed - indexed for MEDLINE]


Malnutrition Is Associated with Increased Liver Stiffness in Type 2 Diabetes: The Mediating Role of Inflammation.
Biomolecules
Lo Buglio A, Bellanti F, Villani R, Capurso C, Magnati GP, Cioffi S, Tedesco G, Torsello CA, Vendemiale G, Serviddio G.
PMID: 41463388 [PubMed - indexed for MEDLINE]


Ultrasound and SWE-based transfer learning for predicting fibrotic NASH.
Sci Rep
Xia F, Wang K, Wang Y, Zhang C, Wang J.
PMID: 41461741 [PubMed - indexed for MEDLINE]


Unveiling the Burden of Steatotic Liver Disease: Mortality Risks by Subtype and Fibrosis Stage in a Nationwide Cohort.
Liver Int
Feng Q, Manousou P, Izzi-Engbeaya CN, Loomba R, Thursz M, Woodward M.
PMID: 41460581 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 37689    Seite 1 von 1885  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1